Nanox Announces Collaboration with AhealthZ and SCL Science to Enter South Korean Market

AhealthZ to aid Nanox’s pursuit of local authorizations and licenses for Nanox.ARC in South Korea

SCL Science to integrate Nanox’s artificial intelligence solutions in operations

PETAH TIKVA, Israel, April 09, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced a new collaboration to advance the Nanox.ARC 3D imaging system and Nanox artificial intelligence (AI) solutions in Korea with AhealthZ – a distributor of healthcare services and devices – and SCL Science, AhealthZ’s affiliated company and subsidiary of global healthcare group SCL (Seoul Clinical Laboratories).

Under the collaboration, AhealthZ plans to assist Nanox in efforts to secure local authorizations and licenses to enable the importation, marketing and sales of the Nanox.ARC in South Korea. The Nanox.ARC is a digital tomosynthesis system that uses multiple sources of X-rays to produce a three-dimensional, tomographic images. Compared to similar X-ray tomosynthesis based devices, Nanox.ARC has a smaller footprint, utilizes a cold cathode system, and has the potential to be a cost-effective and scalable imaging solution in healthcare settings.

The collaboration will also include SCL Science integrating Nanox’s AI solutions in remote image analysis and other operations. Nanox’s AI solutions include its HealthCCSng cardiac solution, HealthOST bone solution and HealthFLD fatty liver solution, and are designed to help identify patients with asymptomatic undetected chronic disease and initiate earlier diagnosis and preventative management. Additionally, Nanox.MARKETPLACE, a teleradiology services platform that provides remote access to radiology and cardiology experts, will potentially be integrated with SCL Science’s teleradiology centers in South Korea and other overseas markets.

“We are excited to work with AhealthZ and SCL Science to bring our comprehensive medical imaging solutions to South Korea, a country of over 51 million people and one of the world’s most advanced technological markets,” said Erez Meltzer, Nanox Chief Executive Officer. “This collaboration is a mutually beneficial opportunity that provides a pathway for Nanox to establish a presence for the Nanox.ARC and expand our AI solutions portfolio, as well as for SCL to leverage cutting-edge AI solutions in its efforts to advance digital health research and professional medical services.”